Recent studies have focused on the convergence of GLP-1|glucose-dependent insulinotropic polypeptide|glucagon receptor agonist therapies and DA neurotransmission. While GIP stimulators are widely employed for treating https://briandmux045801.qodsblog.com/41554014/emerging-gcgr-activators-and-dopaminergic-influence-a-comparative-assessment